ENST00000617316.2:c.546C>T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The ENST00000617316.2(ORAI1):​c.546C>T​(p.Ile182Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.176 in 1,614,070 control chromosomes in the GnomAD database, including 27,597 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2215 hom., cov: 33)
Exomes 𝑓: 0.18 ( 25382 hom. )

Consequence

ORAI1
ENST00000617316.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -0.831

Publications

43 publications found
Variant links:
Genes affected
ORAI1 (HGNC:25896): (ORAI calcium release-activated calcium modulator 1) The protein encoded by this gene is a membrane calcium channel subunit that is activated by the calcium sensor STIM1 when calcium stores are depleted. This type of channel is the primary way for calcium influx into T-cells. Defects in this gene are a cause of immune dysfunction with T-cell inactivation due to calcium entry defect type 1 (IDTICED1). [provided by RefSeq, Sep 2011]
ORAI1 Gene-Disease associations (from GenCC):
  • tubular aggregate myopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • myopathy, tubular aggregate, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • combined immunodeficiency due to ORAI1 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Stormorken syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 12-121641283-C-T is Benign according to our data. Variant chr12-121641283-C-T is described in ClinVar as Benign. ClinVar VariationId is 379393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.831 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ORAI1NR_186857.1 linkn.764C>T non_coding_transcript_exon_variant Exon 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ORAI1ENST00000617316.2 linkc.546C>T p.Ile182Ile synonymous_variant Exon 3 of 3 1 ENSP00000482568.2
ORAI1ENST00000611718.1 linkn.602C>T non_coding_transcript_exon_variant Exon 2 of 2 5
ORAI1ENST00000646827.1 linkn.744C>T non_coding_transcript_exon_variant Exon 2 of 2
ORAI1ENST00000698901.2 linkn.668C>T non_coding_transcript_exon_variant Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.156
AC:
23739
AN:
152110
Hom.:
2209
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0868
Gnomad AMI
AF:
0.259
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.214
Gnomad EAS
AF:
0.253
Gnomad SAS
AF:
0.327
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.160
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.203
AC:
50725
AN:
249926
AF XY:
0.207
show subpopulations
Gnomad AFR exome
AF:
0.0842
Gnomad AMR exome
AF:
0.300
Gnomad ASJ exome
AF:
0.198
Gnomad EAS exome
AF:
0.258
Gnomad FIN exome
AF:
0.119
Gnomad NFE exome
AF:
0.163
Gnomad OTH exome
AF:
0.188
GnomAD4 exome
AF:
0.178
AC:
260437
AN:
1461844
Hom.:
25382
Cov.:
34
AF XY:
0.183
AC XY:
132880
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.0871
AC:
2915
AN:
33480
American (AMR)
AF:
0.294
AC:
13150
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.201
AC:
5244
AN:
26136
East Asian (EAS)
AF:
0.240
AC:
9512
AN:
39700
South Asian (SAS)
AF:
0.331
AC:
28538
AN:
86258
European-Finnish (FIN)
AF:
0.123
AC:
6564
AN:
53406
Middle Eastern (MID)
AF:
0.270
AC:
1557
AN:
5768
European-Non Finnish (NFE)
AF:
0.163
AC:
181535
AN:
1111988
Other (OTH)
AF:
0.189
AC:
11422
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
15835
31670
47504
63339
79174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6672
13344
20016
26688
33360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.156
AC:
23783
AN:
152226
Hom.:
2215
Cov.:
33
AF XY:
0.161
AC XY:
11948
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0871
AC:
3618
AN:
41548
American (AMR)
AF:
0.242
AC:
3701
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.214
AC:
743
AN:
3472
East Asian (EAS)
AF:
0.253
AC:
1310
AN:
5168
South Asian (SAS)
AF:
0.326
AC:
1574
AN:
4824
European-Finnish (FIN)
AF:
0.118
AC:
1250
AN:
10600
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.160
AC:
10899
AN:
67998
Other (OTH)
AF:
0.181
AC:
383
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1053
2105
3158
4210
5263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.171
Hom.:
4338
Bravo
AF:
0.161
Asia WGS
AF:
0.311
AC:
1081
AN:
3478
EpiCase
AF:
0.177
EpiControl
AF:
0.174

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied by a panel of primary immunodeficiencies. Number of patients: 48. Only high quality variants are reported.

Oct 20, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not provided Benign:1Other:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing.

Combined immunodeficiency due to ORAI1 deficiency;C4014557:Myopathy, tubular aggregate, 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
3.4
DANN
Benign
0.79
PhyloP100
-0.83
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3741595; hg19: chr12-122079189; COSMIC: COSV57491137; API